Taisho Pharmaceutical Holdings logo

Taisho Pharmaceutical Holdings

Asia, Tokyo, Japan, Tokyo

Description

Taisho Pharmaceutical Holdings is a pharmaceutical company that provides medical drugs for patients.

Investor Profile

Taisho Pharmaceutical Holdings has backed more than 4 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series D, Series A rounds (top funding stages).
  • Majority of deals are located in United States, Israel.
  • Strong thematic focus on Biotechnology, Health Care, Medical Device.

Stage Focus

  • Series B (25%)
  • Series D (25%)
  • Series A (25%)
  • Series C (25%)

Country Focus

  • United States (75%)
  • Israel (25%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical Device
  • Wearables
  • Artificial Intelligence (Ai)
  • Consumer Goods
  • Machine Learning
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Taisho Pharmaceutical Holdings frequently co-invest with?

AXA Investment Managers
Europe, Ile-de-France, France, Puteaux
Co-Investments: 2
Senvest Management
North America, New York, United States, New York
Co-Investments: 2
Features Capital
North America, Vermont, United States, Norwich
Co-Investments: 3
Hikma Ventures
Europe, England, United Kingdom, London
Co-Investments: 2
RiverVest
North America, Missouri, United States, St Louis
Co-Investments: 3
Aphelion Capital
North America, Colorado, United States, Littleton
Co-Investments: 3
AW
North America, Florida, United States, Miami
Co-Investments: 2
Able Partners
North America, New York, United States, New York
Co-Investments: 1
Alpha Wave Global
North America, Florida, United States, Miami
Co-Investments: 1
M Ventures
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 2

What are some of recent deals done by Taisho Pharmaceutical Holdings?

Biolinq

San Diego, California, United States

Biolinq develops a wearable biosensor platform that is capable of measuring blood level information.

BiotechnologyHealth CareMedical DeviceWearables
Series CApr 22, 2025
Amount Raised: $100,000,000
Biolinq

San Diego, California, United States

Biolinq develops a wearable biosensor platform that is capable of measuring blood level information.

BiotechnologyHealth CareMedical DeviceWearables
Series DApr 4, 2024
Amount Raised: $58,000,000
Biolinq

San Diego, California, United States

Biolinq develops a wearable biosensor platform that is capable of measuring blood level information.

BiotechnologyHealth CareMedical DeviceWearables
Series BNov 2, 2021
Amount Raised: $100,000,000
Moodify

Kefar Sava, HaMerkaz, Israel

Transforming the way scents are made by developing Scent AI technology & solutions for the digitization of scent design

Artificial Intelligence (AI)Consumer GoodsMachine LearningManufacturing
Series AAug 19, 2021
Amount Raised: $8,000,000